Regeneron Can't Ditch COVID-19 Tech Patent Suit
By Lauren Berg · March 2, 2022, 10:54 PM EST
Regeneron Pharmaceuticals Inc. can't escape a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, a New York federal judge ruled Wednesday....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login